138 related articles for article (PubMed ID: 36946202)
1. Digital image analysis of erythroblastic islands in myelodysplastic syndromes.
Zhang R; Drumheller B; Wang LP; Obstfeld AE; Lake JI; Bagg A
Int J Lab Hematol; 2023 Jun; 45(3):289-296. PubMed ID: 36946202
[TBL] [Abstract][Full Text] [Related]
2. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
3. α-Hemoglobin-stabilizing Protein: An Effective Marker for Erythroid Precursors in Bone Marrow Biopsy Specimens.
Yu H; Pinkus JL; Pinkus GS
Appl Immunohistochem Mol Morphol; 2016 Jan; 24(1):51-6. PubMed ID: 25611244
[TBL] [Abstract][Full Text] [Related]
4. Over-expression of tumor necrosis factor-alpha in bone marrow biopsies from patients with myelodysplastic syndromes: relationship to anemia and prognosis.
Stifter G; Heiss S; Gastl G; Tzankov A; Stauder R
Eur J Haematol; 2005 Dec; 75(6):485-91. PubMed ID: 16313260
[TBL] [Abstract][Full Text] [Related]
5. Multicompartmental trauma alters bone marrow erythroblastic islands.
Kelly LS; Munley JA; Pons EE; Coldwell PS; Kannan KB; Efron PA; Mohr AM
J Trauma Acute Care Surg; 2023 Feb; 94(2):197-204. PubMed ID: 36652391
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow infiltration by multiple myeloma causes anemia by reversible disruption of erythropoiesis.
Bouchnita A; Eymard N; Moyo TK; Koury MJ; Volpert V
Am J Hematol; 2016 Jun; 91(4):371-8. PubMed ID: 26749142
[TBL] [Abstract][Full Text] [Related]
7. Dyserythropoiesis of myelodysplastic syndromes.
Lefèvre C; Bondu S; Le Goff S; Kosmider O; Fontenay M
Curr Opin Hematol; 2017 May; 24(3):191-197. PubMed ID: 28072603
[TBL] [Abstract][Full Text] [Related]
8. Age-related inflammatory bone marrow microenvironment induces ineffective erythropoiesis mimicking del(5q) MDS.
Mei Y; Zhao B; Basiorka AA; Yang J; Cao L; Zhang J; List A; Ji P
Leukemia; 2018 Apr; 32(4):1023-1033. PubMed ID: 29263441
[TBL] [Abstract][Full Text] [Related]
9. Unraveling Macrophage Heterogeneity in Erythroblastic Islands.
Seu KG; Papoin J; Fessler R; Hom J; Huang G; Mohandas N; Blanc L; Kalfa TA
Front Immunol; 2017; 8():1140. PubMed ID: 28979259
[TBL] [Abstract][Full Text] [Related]
10. The impact of erythroblast enucleation efficiency on the severity of anemia in patients with myelodysplastic syndrome.
An C; Xue F; Sun L; Han H; Zhang Y; Hu Y
Cell Commun Signal; 2023 Nov; 21(1):332. PubMed ID: 37986081
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical detection of p53, mdm2, waf1/p21, and Ki67 proteins in bone marrow biopsies in myelodysplastic syndroms, acute myelogenous leukaemias and chronic myeloproliferative disorders.
Kanavaros P; Stefanaki K; Rontogianni D; Darivianaki K; Vlychou M; Papadaki E; Eliopoulos G; Bakiri M; Matsouka C; Kakolyris S; Georgoulias V
Clin Exp Pathol; 1999; 47(5):231-8. PubMed ID: 10598372
[TBL] [Abstract][Full Text] [Related]
12. Myelodysplastic/myeloproliferative neoplasms: are morphology and immunophenotyping still relevant?
Sangiorgio VFI; Orazi A; Arber DA
Best Pract Res Clin Haematol; 2020 Jun; 33(2):101139. PubMed ID: 32460987
[TBL] [Abstract][Full Text] [Related]
13. Posttraumatic pneumonia exacerbates bone marrow erythropoietic dysfunction.
Gillies GS; Munley JA; Kelly LS; Kirkpatrick SL; Pons EE; Kannan KB; Bible LE; Efron PA; Mohr AM
J Trauma Acute Care Surg; 2024 Jan; 96(1):17-25. PubMed ID: 37853556
[TBL] [Abstract][Full Text] [Related]
14. In vitro proliferation and differentiation of erythroid progenitors from patients with myelodysplastic syndromes: evidence for Fas-dependent apoptosis.
Claessens YE; Bouscary D; Dupont JM; Picard F; Melle J; Gisselbrecht S; Lacombe C; Dreyfus F; Mayeux P; Fontenay-Roupie M
Blood; 2002 Mar; 99(5):1594-601. PubMed ID: 11861273
[TBL] [Abstract][Full Text] [Related]
15. Impaired formation of erythroblastic islands is associated with erythroid failure and poor prognosis in a significant proportion of patients with myelodysplastic syndromes.
Buesche G; Teoman H; Giagounidis A; Göhring G; Schlegelberger B; Ganser A; Aul C; Kreipe HH
Haematologica; 2016 May; 101(5):e177-81. PubMed ID: 26944473
[No Abstract] [Full Text] [Related]
16. Clinical impact of dysplastic changes in acquired aplastic anemia: A systematic study of bone marrow biopsies in children and adults.
Marchesi RF; Velloso EDRP; Garanito MP; Leal AM; Siqueira SAC; Azevedo Neto RS; Rocha V; Zerbini MCN
Ann Diagn Pathol; 2020 Apr; 45():151459. PubMed ID: 32000075
[TBL] [Abstract][Full Text] [Related]
17. Clinical and cytogenetic findings of myelodysplastic syndromes showing hypocellular bone marrow or minimal dysplasia, in comparison with typical myelodysplastic syndromes.
Toyama K; Ohyashiki K; Yoshida Y; Abe T; Asano S; Hirai H; Hirashima K; Hotta T; Kuramoto A; Kuriya S
Int J Hematol; 1993 Aug; 58(1-2):53-61. PubMed ID: 8219112
[TBL] [Abstract][Full Text] [Related]
18. p53 expression in myeloid cells of myelodysplastic syndromes. Association with evolution of overt leukemia.
Kitagawa M; Yoshida S; Kuwata T; Tanizawa T; Kamiyama R
Am J Pathol; 1994 Aug; 145(2):338-44. PubMed ID: 8053492
[TBL] [Abstract][Full Text] [Related]
19. Dyserythropoiesis in the diagnosis of the myelodysplastic syndromes and other myeloid neoplasms: problem areas.
Goasguen JE; Bennett JM; Bain BJ; Brunning R; Vallespi MT; Tomonaga M; Zini G; Renault A;
Br J Haematol; 2018 Aug; 182(4):526-533. PubMed ID: 29917221
[TBL] [Abstract][Full Text] [Related]
20. MDS overlap disorders and diagnostic boundaries.
Tanaka TN; Bejar R
Blood; 2019 Mar; 133(10):1086-1095. PubMed ID: 30670443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
